Malononitrilamides: a New Strategy of Immunosuppression for Allo- and Xenotransplantation
- 1 May 1998
- journal article
- review article
- Published by Elsevier in Transplantation Proceedings
- Vol. 30 (3) , 884-890
- https://doi.org/10.1016/s0041-1345(98)00086-4
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Malononitrilamides (MNA 279 and MNA 715) have therapeutic activity in acute and chronic relapsing experimental allergic encephalomyelitis (EAE)Inflammation Research, 1997
- Prevention of the development of murine systemic lupus erythematosus (SLE)-like diseases by the malononitrilamides MNA 279 and MNA 715Inflammation Research, 1997
- Malononitrilamides inhibit the development of systemic lupus erythematosus (SLE)-like diseasesImmunology Letters, 1997
- Treatment of various graft-versus-host diseases in rodents by malononitrilamides (MNAs)Immunology Letters, 1997
- Malononitrilamides inhibit T- and B-cell responsiveness in different speciesTransplantation Proceedings, 1997
- Analogues of leflunomide's primary metabolite, the malononitrilamides, prevent the development of graft-versus-host diseaseTransplantation Proceedings, 1997
- Dihydroorotate Dehydrogenase Is a High Affinity Binding Protein for A77 1726 and Mediator of a Range of Biological Effects of the Immunomodulatory CompoundJournal of Biological Chemistry, 1995
- Localization of dihydroorotate oxidase in myocardium and kidney cortex of the ratHistochemistry and Cell Biology, 1995
- Diagnosis and Treatment of Inborn Errors of Purine and Pyrimidine Metabolism: An OverviewPublished by Springer Nature ,1995
- A LYMPH NODE WEIGHT ASSAY FOR THE GRAFTVERSUS- HOST ACTIVITY OF RAT LYMPHOID CELLSTransplantation, 1970